---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-013457"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2022-03-18T23:59:59+00:00"
generated_at: "2026-06-26T21:44:48.843921+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InMed CFO Bruce Colwill retiring; Brenda Edwards named interim CFO

## Summary
- Bruce Colwill steps down as CFO effective March 31, 2022; will remain advisor through June 30, 2022.
- Brenda Edwards appointed interim CFO effective April 1, 2022; over 35 years of experience including 20+ years as CFO.
- Company has initiated a search for a permanent CFO replacement.
- Ms. Edwards engaged through a placement agency at CAD$210/hour.

## SEC filing metadata
- accession: 0001213900-22-013457
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2022-03-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390022013457/0001213900-22-013457-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390022013457/ea157098-8k_inmedpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-013457
- JSON: https://secwatch.observer/filing/0001213900-22-013457.json
- Plain text: https://secwatch.observer/filing/0001213900-22-013457.txt

## Key facts
- Executive change
  Brenda Edwards was appointed as Interim Chief Financial Officer at InMed Pharmaceuticals Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: The Company appointed Ms. Brenda Edwards as Interim Chief Financial Officer of the Company effective April 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022013457/0001213900-22-013457-index.htm
- Executive change
  Bruce Colwill retired as Chief Financial Officer at InMed Pharmaceuticals Inc..
  - Action: retired
  - Role: Chief Financial Officer
  source text: Mr. Bruce Colwill, will be retiring and will be stepping down from his position at the Company effective March 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000121390022013457/0001213900-22-013457-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.